Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

India–Chile Trade Talks Likely To Resume In December For Key CEPA Negotiations

India–Chile Trade Talks Likely To Resume In December For Key CEPA Negotiations

Primary Market Slowdown Next Week As Only Two IPOs Open, Excelsoft Technologies & Gallard Steel...

Primary Market Slowdown Next Week As Only Two IPOs Open, Excelsoft Technologies & Gallard Steel...

Finance Ministry To Resume Pre-Budget 2026–27 Consultations From Nov 18, Set For Week-Long Talks...

Finance Ministry To Resume Pre-Budget 2026–27 Consultations From Nov 18, Set For Week-Long Talks...

SC To Take Up Sahara Staff Salary Petitions On Monday, Key Pleas On Property Sale To Adani Group...

SC To Take Up Sahara Staff Salary Petitions On Monday, Key Pleas On Property Sale To Adani Group...

India’s Top Companies Add Over ₹2 Lakh Crore In Market Value As Equity Indices Rebound Sharply...

India’s Top Companies Add Over ₹2 Lakh Crore In Market Value As Equity Indices Rebound Sharply...